Clinical trial
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels…
NCT00145405 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00145405 |
|---|---|
| Title | Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction |
| Official title | Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - A Twelve Month Randomized Cross-Over Study in Patients With Acromegaly |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Lanreotide Autogel and Octreotide LAR |
| Enrollment | 12 |
| Start date | Sep 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: